Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Akoya Biosciences, Inc. (AKYA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
12.87-0.53 (-3.96%)
At close: 04:00PM EST
12.87 0.00 (0.00%)
After hours: 04:01PM EST
Advertisement

Akoya Biosciences, Inc.

100 Campus Drive
6th Floor
Marlborough, MA 01752
United States
855 896 8401
https://www.akoyabio.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees319

Key Executives

NameTitlePayExercisedYear Born
Mr. Brian McKelligonPres, CEO & Director566.93kN/A1969
Dr. Garry P. Nolan Ph.D.Co-Founder, Independent Director & Head of the Scientific Advisory Board22.5kN/A1962
Mr. Joseph S. DriscollChief Financial Officer467.98kN/A1965
Dr. Frederic G. Pla Ph.D.Chief Operating Officer445.27kN/A1959
Dr. Nikolay Samusik Ph.D.Co-FounderN/AN/AN/A
Dr. Yury Goltsev Ph.D.Co-FounderN/AN/AN/A
Mr. Clifford C. HoytVP of Translational & Scientific AffairsN/AN/AN/A
Priyam ShahSr. Director of Bus. Devel. & Investor Relations StrategyN/AN/AN/A
Mr. Paul GrassSr. VP of SalesN/AN/AN/A
Ms. Marilee Moy M.B.A.Chief People OfficerN/AN/A1959
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Corporate Governance

Akoya Biosciences, Inc.’s ISS Governance QualityScore as of November 28, 2022 is 9. The pillar scores are Audit: 3; Board: 10; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement